on the activities in uitro of microsomal drug-metabolizing enzymes in the liver.
Steroids were administered to male 38-day-old Wistar albino rats, intraperitoneally (7.65pmol/kg body wt.), once daily for 7 consecutive days. The last dose was given 16h before the animals were killed. Changes in body weights of the animals during the pretreatment period were recorded. Microsomal protein was measured by the method of Lowry et al. (1951) and the cytochrome P-450 content by that of Omura & Sato (1964) . Biphenyl 4-hydroxylase activity was assayed by the method of Creaven et al. (1965) , benzo[a]pyrene 3-hydroxylase activity by the method of Kuntzman et a/. (1966) and aniline 4-hydroxylase activity as described by Nakanishi et al. (1971) . Table 1 shows that 7-day pretreatment of rats with betamethasone impaired growth (19 %) and that 7-day pretreatment with prednisolone increased liver microsomal protein content (34%). Of the three steroids studied, only corticosterone, the endogenous glucocorticoid in the rat, resulted in inhibition of enzyme activity of biphenyl 4-hydroxylase, benzo[alpyrene 3-hydroxylase and aniline 4-hydroxylase (Table 2 ). This is in agreement with the Radzialowski & Bousquet (1968) , whose work showed that maintenance of elevated plasma corticosterone concentrations in the rat results in a considerable decrease in the basal activities of hepatic aminopyrine demethylase and p-nitroanisole demethylase. Prednisolone and betamethasone both induced some of the drugmetabolizing enzymes in the rat, though their modes of action seemed to be different. With prednisolone-pretreated rats the specific activities of the enzymes assayed were not significantly changed from those of controls (80, 97 and 103 % of control values for biphenyl 4-hydroxylase, benzo[a]pyrene 3-hydroxylase and aniline 4-hydroxylase respectively) and the increase in activities per unit weight of tissue was primarily due to anabolic effects of prednisolone on the liver. In contrast, betamethasone caused marked increases in the specific activities of hepatic biphenyl 4-hydroxylase (133 % of control) and aniline 4-hydroxylase (160 % of control), though benzo[a]pyrene 3-hydroxylase (105 % of control) was not affected by betamethasone to the same extent as reported by other workers (Somogyi et al., 1971) . This lower benzo[a]pyrene 3-hydroxylase activity observed in betamethasone-treated rats may be attributed to the smaller dose used in these experiments compared with that in the work of Somogyi etal. (1971) . The induction of biphenyl 4-hydroxylase and aniline 4-hydroxylase activities, expressed per mol of cytochrome P-450, may possibly, in the case of betamethasone, be due to an increase in Vol. 1 BIOCHEMICAL SOCIETY TRANSACTIONS cytochrome P-450 reduction. Similar observations were made by Stripp et al. (1970) with spironolactone in the rat. The present study provides evidence that, in the rat, the effects of glucocorticoids on the microsomal drug-metabolizing enzymes of the liver vary according to the particular steroid used, and may give rise to inhibition or induction. The apparent differences between the modes of induction by prednisolone and betamethasone remain to be elucidated.
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